Skip to main navigation
Skip to search
Skip to main content
Sort by
INIS
women
100%
pregnancy
55%
birth
41%
risks
40%
delivery
37%
labor
35%
netherlands
31%
prediction
24%
hospitals
18%
comparative evaluations
17%
hemorrhage
17%
cost
16%
obstetrics
15%
patients
14%
decision making
14%
guidelines
14%
length
14%
validation
13%
interventions
13%
doses
12%
implementation
10%
data
10%
populations
10%
reviews
9%
infants
9%
symptoms
9%
design
9%
management
9%
blood
9%
children
9%
Medicine and Dentistry
Premature Labor
26%
Randomized Controlled Trial
22%
Cesarean Section
19%
Pre-Eclampsia
18%
Prediction Model
15%
Health Care Cost
13%
Prospective Cohort Study
12%
Cervical Length Measurement
12%
Counseling
11%
Obstetrics
10%
Pregnant Woman
10%
Lochia
10%
Gestational Age
10%
Decision Making
9%
Hyperemesis Gravidarum
9%
First Trimester Pregnancy
8%
Pessary
8%
Prematurity
8%
Vaginal Birth after Cesarean
7%
Preterm Delivery
6%
Acetylsalicylic Acid
6%
Fibronectin
6%
Fetus Growth
6%
Low Drug Dose
6%
Cohort Analysis
6%
Retrospective Cohort Study
6%
Placebo
5%
Hypertension
5%
Keyphrases
Randomized Controlled Trial
13%
Prediction Model
12%
Prospective Cohort Study
11%
Pregnant Women
10%
Preeclampsia
10%
Dutch
10%
Hyperemesis Gravidarum
9%
Postpartum Hemorrhage
9%
Cervical Length
9%
Prenatal Counseling
8%
Counseling
8%
Week of Gestation
7%
During Pregnancy
7%
Preterm Birth
7%
External Validation
7%
Cesarean Section (C-section)
6%
Maternal Outcomes
6%
Cost-effectiveness
6%
Low-dose Aspirin
6%
Extreme Prematurity
6%
Spontaneous Preterm Birth (sPTB)
5%
Fetal Fibronectin
5%
Vaginal Birth
5%
Previous Cesarean Section
5%
Cervical Pessary
5%
Obstetricians
5%
Threatened Preterm Labor
5%
Placebo
5%
First Trimester
5%
Cervical Length Measurement
5%
